Skip to main content
  • CABG Better for Non-Diabetic Multivessel CAD Long-term survival results in meta-analysis akin to those in diabetes

    Non-diabetic patients with multivessel coronary artery disease (CAD) do better long-term with coronary artery bypass graft (CABG) surgery than with percutaneous coronary intervention (PCI), according to pooled patient-level trial data.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details